Muhammed Dawood | Pharmacogenomics and Personalized Medicine | Best Researcher Award

Mr. Muhammed Dawood | Pharmacogenomics and personalized medicine | Best Researcher Award

Computer Science Department | United Kingdom

Author Profile

Google Scholar

EARLY ACADEMIC PURSUITS

Muhammad Dawood's academic journey began with a Bachelor's in Computer Software Engineering from the University of Engineering and Technology (UET) Peshawar, Pakistan, where his thesis explored a novel approach for Quran learning using Neuro-Linguistic Programming (NLP) and Total Physical Interaction (TPI) in handheld devices. He continued his studies with a Master's in Computer Science from the Pakistan Institute of Engineering and Applied Sciences (PIEAS), Islamabad, focusing on the analysis of hurricane satellite imagery.

PROFESSIONAL ENDEAVORS

Following his master's, Dawood gained teaching and industrial experience. As a Lecturer at the Department of Software Engineering, University of Science & Technology Bannu, Pakistan, he taught various courses, supervised undergraduate final year projects, and served as a coordinator. Additionally, he worked as a Machine Learning Engineer at INTAQSOL Islamabad, Pakistan, before embarking on his Ph.D. journey at the TIA Research Centre, Computer Science Department, University of Warwick.

CONTRIBUTIONS AND RESEARCH FOCUS ON PHARMACOGENOMICS AND PERSONALIZED MEDICINE

Dawood's contributions span a diverse range of projects, reflecting his expertise in computational pathology, genomic data science, machine learning, and software engineering. Notable projects include gene expression prediction, cellular composition prediction, and drug sensitivity prediction from histology images. His research also delves into hurricane intensity prediction, personalized aesthetic-based apparel recommendation, and sentiment analysis of Twitter tweets.

IMPACT AND INFLUENCE

Muhammad Dawood's impactful work is underscored by numerous achievements. He secured a fully funded studentship for his Ph.D. studies from GlaxoSmithKline and received the Best Paper Award at ICCV CDpath 2021. His teaching contributions as a Graduate Teaching Assistant at the University of Warwick further showcase his commitment to academic excellence.

ACADEMIC CITES

Dawood's research, particularly in the field of computational pathology and genomics, has likely garnered attention within the academic community. While specific citation metrics are not provided, his Best Paper Award at ICCV CDpath 2021 suggests recognition and appreciation for the quality of his work.

LEGACY AND FUTURE CONTRIBUTIONS

As a fourth-year Ph.D. student, Dawood's legacy includes a diverse portfolio of projects that contribute to the understanding of cellular processes, cancer therapy personalization, and drug design. His future contributions are anticipated to further advance the fields of machine learning, computational pathology, and genomic data science, leaving a lasting impact on personalized medicine and beyond.

Notable Publications

SlideGraph+: Whole slide image level graphs to predict HER2 status in breast cancer 2022(47)

Deep-PHURIE: deep learning based hurricane intensity estimation from infrared satellite imager  2020(37)

CoNIC Challenge: Pushing the frontiers of nuclear detection, segmentation, classification and counting 2023(5)

Alban Deo Christian | Chirurgie Maxillo-Faciale | Young Scientist Award

Dr. Alban Deo Christian | Chirurgie Maxillo-Faciale | Young Scientist Award

CHU Mohammed VI, Marrakech | Morocco

AUTHOR PROFILE

ORCID Id 

EARLY ACADEMIC PURSUITS

Alban Déo Christian OPANGO began his academic journey in Brazzaville, Congo, achieving academic excellence early on. In 2002, he obtained the Certificate of Primary and Elementary Studies (CEPE), followed by the Brevet d’Etudes du Premier Cycle (BEPC) in 2006. His commitment to education continued as he earned the BACCALAUREAT SERIE C Diploma in June 2009, specializing in mathematics with a focus on physical sciences.

PROFESSIONAL ENDEAVORS

Embarking on a career in medicine, OPANGO commenced medical studies at the Faculty of Health Sciences, Marien Ngouabi University, in October 2009. This academic pursuit spanned from October 2009 to June 2017, shaping the foundation of his medical knowledge and skills.

CONTRIBUTIONS AND RESEARCH FOCUS ON CHIRURGIE MAXILLO-FACIALE

OPANGO's research culminated in a significant thesis titled "Anatomo-scanographic Study of the Arterial Vascularization of the Liver in Congolese Melanoderma Subjects." Defended on December 4, 2017, at the Faculty of Health Sciences, Marien Ngouabi University, the thesis garnered high praise, earning him a "Very Honorable" mention with congratulations from the jury.

IMPACT AND INFLUENCE

Following his academic achievements, OPANGO delved into professional experiences that showcased his dedication to healthcare. From September 2016 to December 2018, he served as a Doctor at the Talangai Reference Hospital, contributing to the well-being of the community. Additionally, his role as a Contract Doctor at the Maison Médicale France – Congo Clinic (MMFC) from January 2017 to December 2018 further expanded his professional repertoire.

ACADEMIC CITES

OPANGO's contributions extend beyond clinical practice, with a focus on academic excellence. In April 2023, he obtained a Certificate in the Management of Health Establishments, demonstrating his commitment to continuous learning and professional development.

LEGACY AND FUTURE CONTRIBUTIONS

With a robust educational background, successful thesis defense, and impactful professional experiences, OPANGO has laid the groundwork for a promising career in the medical field. His legacy includes a commitment to excellence, research, and the provision of quality healthcare services. As he navigates the path ahead, OPANGO is poised to make further contributions to the medical community and society at large.

Notable Publications

Cleft palate in Pierre Robin syndrome: A Review of 7 cases 2023

Eccrine spiradenoma of nose: Surgical case report 2023

Award Subject track

Introduction to Emerging Trends in Genetics and Genomics Research: The field of genetics and genomics is continually evolving, with rapid advancements shaping our understanding of the genetic basis of life, health, and disease. Emerging trends in genetics and genomics research represent the forefront of scientific inquiry, offering exciting opportunities to uncover new insights, develop innovative technologies, and transform healthcare.

Subtopics in Emerging Trends in Genetics and Genomics Research:

Single-Cell Genomics: Explore the burgeoning field of single-cell genomics, which enables the study of individual cells' genetic information, uncovering cellular heterogeneity, tissue development, and disease mechanisms at an unprecedented level of resolution.

Functional Genomics: Investigate how functional genomics approaches, such as CRISPR-Cas9 screens and high-throughput sequencing, are revolutionizing our ability to decipher gene function, regulatory networks, and the molecular basis of diseases.

Epitranscriptomics: Delve into the study of RNA modifications, known as epitranscriptomics, which has gained prominence for its role in post-transcriptional gene regulation, mRNA stability, and its implications in diseases like cancer and neurological disorders.

Precision Medicine and Pharmacogenomics: Discuss the growth of precision medicine and pharmacogenomics, where genetic information is used to tailor medical treatments to individual patients, optimizing drug selection and dosages for improved therapeutic outcomes.

Synthetic Biology and Genome Editing: Highlight the exciting developments in synthetic biology and genome editing technologies like CRISPR-Cas9, which are transforming genetic engineering, biotechnology, and the potential for gene therapy in treating genetic disorders.

These emerging trends reflect the dynamic nature of genetics and genomics research, offering new avenues for understanding the genetic code, unraveling disease mechanisms, and harnessing genetic information for the benefit of personalized medicine and human health.

[post_grid id="9728"]

Emerging trends in genetics and genomics research

Emerging trends in genetics and genomics research

Introduction to Emerging Trends in Genetics and Genomics Research: The field of genetics and genomics is continually evolving, with rapid advancements shaping our understanding of the genetic basis of life, health, and disease. Emerging trends in genetics and genomics research represent the forefront of scientific inquiry, offering exciting opportunities to uncover new insights, develop innovative technologies, and transform healthcare.

Subtopics in Emerging Trends in Genetics and Genomics Research:

Single-Cell Genomics: Explore the burgeoning field of single-cell genomics, which enables the study of individual cells’ genetic information, uncovering cellular heterogeneity, tissue development, and disease mechanisms at an unprecedented level of resolution.

Functional Genomics: Investigate how functional genomics approaches, such as CRISPR-Cas9 screens and high-throughput sequencing, are revolutionizing our ability to decipher gene function, regulatory networks, and the molecular basis of diseases.

Epitranscriptomics: Delve into the study of RNA modifications, known as epitranscriptomics, which has gained prominence for its role in post-transcriptional gene regulation, mRNA stability, and its implications in diseases like cancer and neurological disorders.

Precision Medicine and Pharmacogenomics: Discuss the growth of precision medicine and pharmacogenomics, where genetic information is used to tailor medical treatments to individual patients, optimizing drug selection and dosages for improved therapeutic outcomes.

Synthetic Biology and Genome Editing: Highlight the exciting developments in synthetic biology and genome editing technologies like CRISPR-Cas9, which are transforming genetic engineering, biotechnology, and the potential for gene therapy in treating genetic disorders.

These emerging trends reflect the dynamic nature of genetics and genomics research, offering new avenues for understanding the genetic code, unraveling disease mechanisms, and harnessing genetic information for the benefit of personalized medicine and human health.

Genetic epidemiology and population genetics

Genetic epidemiology and population genetics

Introduction to Genetic Epidemiology and Population Genetics: Genetic epidemiology and population genetics are integral fields in the study of how genetic factors interact with populations and influence the prevalence of diseases. Genetic epidemiology investigates the role of genetics in disease occurrence, while population genetics focuses on the genetic variation within and between populations. Together, these fields provide critical insights into the complex interplay between genes, environment, and health.

Subtopics in Genetic Epidemiology and Population Genetics:

  1. Disease Mapping: Explore how genetic epidemiology is used to map disease genes, identify disease risk loci, and understand the genetic architecture of complex traits by studying the distribution of genetic variants in populations.
  2. Genome-Wide Association Studies (GWAS): Discuss the application of GWAS in genetic epidemiology to uncover associations between genetic markers and diseases, revealing valuable insights into disease susceptibility and risk factors.
  3. Founder Effects and Genetic Drift: Investigate the impact of founder effects and genetic drift in small, isolated populations, leading to the fixation of specific alleles and an increased prevalence of certain genetic disorders.
  4. Genetic Ancestry and Disease Risk: Analyze the relationship between genetic ancestry and disease risk, considering how population-specific genetic variants contribute to disparities in disease prevalence among different ethnic groups.
  5. Evolutionary Genetics: Delve into the field of evolutionary genetics within population genetics, exploring how genetic variation arises, spreads, and adapts to environmental changes, shedding light on the evolutionary history of populations and species.

These subtopics highlight the interdisciplinary nature of genetic epidemiology and population genetics, emphasizing their significance in unraveling the genetic and environmental factors that shape health and disease patterns across diverse populations.

Infectious diseases and host genetics

Infectious diseases and host genetics 

Introduction to Infectious Diseases and Host Genetics: The relationship between infectious diseases and host genetics is a captivating field of research that explores how an individual’s genetic makeup can influence susceptibility to, severity of, and response to infectious pathogens. Understanding the interplay between host genetics and infectious agents provides crucial insights into disease susceptibility, transmission dynamics, and the development of personalized approaches to prevention and treatment.

Subtopics in Infectious Diseases and Host Genetics:

Genetic Susceptibility to Infections: Investigate the genetic factors that render some individuals more susceptible to specific infectious diseases, such as HIV, tuberculosis, or malaria, and how variations in host genes influence disease outcomes.

Host Immune Response Genes: Explore the role of host immune response genes, including those involved in the innate and adaptive immune systems, in influencing an individual’s ability to mount an effective defense against pathogens.

Resistance to Infectious Diseases: Examine instances of genetic resistance to infectious diseases, such as the CCR5Δ32 mutation conferring resistance to HIV infection, and the implications for understanding disease transmission and prevention.

Pharmacogenomics in Infectious Disease Treatment: Discuss how host genetics can impact the efficacy and safety of antiviral and antimicrobial medications, leading to personalized treatment strategies for infectious diseases.

Disease Outcomes and Severity: Analyze how host genetic variations contribute to differences in disease outcomes and severity, considering factors such as cytokine production, host-pathogen interactions, and the development of chronic infections.

These subtopics underscore the intricate relationship between host genetics and infectious diseases, providing insights into the complex mechanisms that govern disease susceptibility, progression, and treatment responses.

Immunogenetics and autoimmune diseases

Immunogenetics and autoimmune diseases

Introduction to Immunogenetics and Autoimmune Diseases: Immunogenetics is a fascinating field that explores the genetic basis of the immune system’s function and its role in health and disease. A significant focus of immunogenetics is the understanding of autoimmune diseases, conditions where the immune system mistakenly targets and damages the body’s own tissues. Studying the genetic factors involved in autoimmune diseases is critical for unraveling their complex origins and developing targeted therapies.

Subtopics in Immunogenetics and Autoimmune Diseases:

Genetic Susceptibility: Investigate the genetic factors that predispose individuals to autoimmune diseases, such as rheumatoid arthritis, multiple sclerosis, and type 1 diabetes, shedding light on the inheritance patterns and specific susceptibility genes.

HLA Associations: Explore the major histocompatibility complex (MHC), particularly the human leukocyte antigen (HLA) genes, and their crucial role in autoimmune diseases, including the diverse HLA alleles associated with increased disease risk.

Epigenetics and Autoimmunity: Examine the epigenetic modifications in autoimmune diseases, revealing how changes in DNA methylation and histone modifications can influence immune responses and contribute to autoimmunity.

Autoimmune Disease Classification: Discuss the classification of autoimmune diseases based on immunogenetic factors and clinical characteristics, providing insights into disease mechanisms and tailored treatment approaches.

Immunotherapy and Precision Medicine: Highlight the emerging field of immunogenetics in immunotherapy and precision medicine for autoimmune diseases, including the development of targeted biologics and immunomodulatory therapies.

Understanding the interplay between genetics and the immune system in autoimmune diseases is pivotal for advancing our knowledge of disease mechanisms, improving diagnostic tools, and developing more effective and personalized treatments for affected individuals.

Metabolic disorders and their genetic basis

Metabolic disorders and their genetic basis 

Introduction to Metabolic Disorders and Their Genetic Basis: Metabolic disorders encompass a diverse group of conditions characterized by disruptions in normal biochemical processes within the body. These disorders can result from genetic mutations that impact enzymes, transport proteins, or metabolic pathways, leading to the accumulation or deficiency of specific molecules. Understanding the genetic basis of metabolic disorders is essential for diagnosis, treatment, and ongoing research aimed at improving the lives of affected individuals.

Subtopics in Metabolic Disorders and Their Genetic Basis:

Phenylketonuria (PKU): Explore the genetic basis of PKU, a metabolic disorder caused by mutations in the PAH gene, leading to the inability to metabolize phenylalanine, and its implications for diagnosis and dietary management.

Gaucher Disease: Investigate the genetic mutations underpinning Gaucher disease, a lysosomal storage disorder resulting from mutations in the GBA gene, leading to the buildup of glucocerebroside and its impact on various organ systems.

Alkaptonuria: Examine the genetic basis of alkaptonuria, a rare metabolic disorder resulting from mutations in the HGD gene, which leads to the accumulation of homogentisic acid and its effects on connective tissues and joints.

Maple Syrup Urine Disease (MSUD): Analyze the genetic basis of MSUD, a disorder caused by mutations in the BCKDHA, BCKDHB, or DBT genes, impacting the breakdown of branched-chain amino acids and resulting in neurological symptoms.

Mitochondrial Disorders: Explore the genetic complexity of mitochondrial disorders, including mutations in both nuclear and mitochondrial DNA, and their effects on cellular energy production, leading to a wide range of clinical presentations.

Understanding the genetic basis of metabolic disorders not only aids in diagnosis but also informs the development of targeted therapies and interventions to manage these conditions effectively

Case studies of genetic diseases and their management

Case studies of genetic diseases and their management

Introduction to Case Studies of Genetic Diseases and Their Management: Case studies of genetic diseases provide valuable insights into the clinical manifestations, genetic basis, and management strategies for individuals affected by these conditions. By examining real-world cases, healthcare professionals, researchers, and students can gain a deeper understanding of the complexities involved in diagnosing and treating genetic disorders, ultimately improving patient care and outcomes.

Subtopics in Case Studies of Genetic Diseases and Their Management:

  1. Cystic Fibrosis: Explore a case study on cystic fibrosis, focusing on the genetic mutations involved, clinical symptoms, diagnostic approaches, and therapeutic interventions such as CFTR modulator therapies.
  2. Down Syndrome: Investigate a case study of Down syndrome, discussing the genetic basis, clinical features, early interventions, and support strategies for individuals with this chromosomal disorder.
  3. Phenylketonuria (PKU): Examine a case study of PKU, highlighting the genetic mutations leading to this metabolic disorder, newborn screening methods, dietary management, and long-term health outcomes.
  4. Tay-Sachs Disease: Analyze a case study of Tay-Sachs disease, including the
  5. mutations, neurological symptoms, genetic counseling considerations, and palliative care for affected individuals.
  6. Hereditary Cancer Syndromes: Explore case studies of hereditary cancer syndromes such as BRCA-associated breast and ovarian cancer, Lynch syndrome, and familial adenomatous polyposis (FAP), focusing on genetic testing, risk assessment, and cancer prevention strategies.

These case studies offer a practical and comprehensive approach to understanding the genetic basis of diseases, their clinical management, and the broader implications for patients and their families.

ethical issues in genetics

ethical issues in genetics 

Introduction to Ethical Issues in Genetics: Ethical considerations are paramount in the field of genetics, given the profound implications of genetic information on individuals, families, and society. As genetic technologies advance, a myriad of ethical dilemmas arise, ranging from questions about privacy and consent to issues of equity and justice in accessing genetic testing and therapies. Understanding and addressing these ethical concerns are crucial for responsible and equitable progress in genetics.

Subtopics in Ethical Issues in Genetics:

Genetic Privacy: Examine the challenges of protecting individuals’ genetic privacy in the age of genomic medicine, discussing issues related to data security, consent for genetic testing, and the potential for unauthorized access.

Informed Consent: Explore the complex landscape of informed consent in genetic testing and research, considering the need for comprehensive education and the ability to make autonomous decisions about genetic information.

Genetic Discrimination: Discuss the ethical dilemmas surrounding genetic discrimination, including issues related to insurance coverage, employment, and access to healthcare based on genetic information.

Gene Editing and CRISPR: Analyze the ethical implications of gene editing technologies like CRISPR-Cas9, including concerns about the potential for germline editing and unforeseen consequences of genetic modifications.

Equity and Access: Address the ethical challenges of ensuring equitable access to genetic testing, therapies, and genomic medicine, considering socioeconomic disparities and the need for fairness in genetic healthcare delivery.

These subtopics highlight the multifaceted ethical landscape in genetics and underscore the importance of ethical frameworks and guidelines to navigate the responsible use of genetic information and technologies.